HealthIs Alzheimer’s drug donanemab really a 'turning point' for treatment? The experimental drug donanemab slows the progression of Alzheimer's disease compared with a placebo, but the effect may not be large enough to be noticed by people with the condition or their families News
HealthHow new fetal therapies are treating genetic conditions in the womb A genetic condition that sees children develop almost no teeth or sweat glands can now be treated by injecting a protein into the amniotic fluid, in just one of a number of new therapies that act before a child is even born News